Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Chem Pharm Bull (Tokyo) ; 67(12): 1278-1283, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31787654

RESUMO

The progesterone receptor (PR) plays an important role in various physiological processes, especially in the female reproductive system, and abnormalities of PR function are associated with several diseases, including some types of cancer. Non-steroidal PR ligands are of interest as candidate drugs for treatment of PR-related diseases without the serious adverse effects that may be caused by steroidal ligands. For the development of non-steroidal PR ligands, both a hydrophobic backbone and a polar functional group corresponding to the 3-carbonyl group of progesterone, which interacts with Gln725 and Arg766 of the PR-ligand binding domain, are critically important. We previously showed that carborane is a useful hydrophobic pharmacophore for PR antagonists, and in this work, we introduced the pentafluorosulfanyl (SF5) group as a novel polar functional group of carborane-based non-steroidal PR antagonists. All the synthesized SF5-containing carborane derivatives exhibited PR-antagonistic activity at micromolar or submicromolar concentration. Among them, compounds 11 are potent progesterone antagonists with submicromolar IC50 values.


Assuntos
Boro/farmacologia , Fluoretos/farmacologia , Receptores de Progesterona/antagonistas & inibidores , Compostos de Enxofre/farmacologia , Boro/química , Fluoretos/química , Humanos , Interações Hidrofóbicas e Hidrofílicas , Estrutura Molecular , Relação Estrutura-Atividade , Compostos de Enxofre/química
2.
Bioorg Med Chem ; 22(19): 5329-37, 2014 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-25151087

RESUMO

Progesterone receptor (PR) regulates various physiological processes, including the female reproductive system, and development of nonsteroidal PR antagonists is considered desirable for clinical application, as they are expected to have reduced side effects. We have synthesized a series of nonsteroidal PR antagonists using a 4-cyanophenyl-p-carborane core structure. Among them, compound 14d exhibited potent PR-antagonistic activity (IC50: 27 nM). It showed high binding affinity for PR, but did not bind to androgen receptor or estrogen receptor. This PR-selective antagonist may be a promising lead compound for clinically applicable progesterone receptor modulators.


Assuntos
Boranos/farmacologia , Nitrilas/farmacologia , Receptores de Progesterona/antagonistas & inibidores , Boranos/síntese química , Boranos/química , Relação Dose-Resposta a Droga , Feminino , Humanos , Simulação de Acoplamento Molecular , Estrutura Molecular , Nitrilas/síntese química , Nitrilas/química , Relação Estrutura-Atividade , Células Tumorais Cultivadas
3.
Eur J Med Chem ; 84: 264-77, 2014 Sep 12.
Artigo em Inglês | MEDLINE | ID: mdl-25036787

RESUMO

The progesterone receptor (PR) plays important roles in multiple physiological processes, including female reproduction. Here, we report the synthesis of nonsteroidal PR antagonists containing a boron cluster as the hydrophobic core. We found that 1,7-diphenyl-meta-carborane was the preferred substructure among the three carborane isomers. Compound 39 was the most potent PR antagonist (IC50: 29 nM). Compound 41 also exhibited potent activity (IC50: 93 nM), and did not bind to androgen receptor, glucocorticoid receptor or mineralocorticoid receptor. These compounds may be useful for investigating potential clinical applications of PR modulators.


Assuntos
Acetanilidas/química , Acetanilidas/farmacologia , Compostos de Boro/química , Compostos de Boro/farmacologia , Desenho de Fármacos , Receptores de Progesterona/antagonistas & inibidores , Acetanilidas/síntese química , Compostos de Boro/síntese química , Relação Dose-Resposta a Droga , Humanos , Interações Hidrofóbicas e Hidrofílicas , Modelos Moleculares , Estrutura Molecular , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...